post featured image

IMPACT researchers named on Highly Cited Researchers list

12 February 2024

Nine Deakin University academics have been named among the world’s most influential researchers in their fields following the release of the 2023 Clarivate™ Highly Cited Researchers™ list. Four of the members are researchers at IMPACT.

A Highly Cited Researcher is an individual who has demonstrated significant and broad influence in their field(s) of research.

Each Deakin researcher selected has authored multiple Highly Cited Papers™ which rank in the top 1% by citations for their field(s) and publication year in the Web of Science over the past decade.

Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1000.

Deakin Deputy Vice-Chancellor (Research and Innovation) Alfred Deakin Professor Matthew Clarke commended Deakin’s academics for being acknowledged among the top researchers internationally.

‘The Deakin community is very proud of the achievements of researchers named in the Highly Cited Researchers list,’ Professor Clarke says.

‘The list highlights Deakin as a home of some of the world’s leading researchers, recognised for their impactful contributions to the communities they serve.’

‘The Highly Cited Researchers list identifies and celebrates exceptional individual researchers at Deakin whose significant and broad influence in their fields translates to impact in their research community and innovations that make the world healthier, more sustainable and more secure,’ David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate says.

‘Their contributions resonate far beyond their individual achievements, strengthening the foundation of excellence and innovation in research,’ he says.

IMPACT Highly Cited Researchers for 2023

Alfred Deakin Professor Felice Jacka OAM


Prof. Jacka is widely regarded as being responsible for the development of the highly innovative field of ‘nutritional psychiatry’, establishing diet as a risk factor and treatment target for common mental disorders.

  • Awarded a Medal of the Order of Australia (OAM) in 2021 for her services to nutritional psychiatry.
  • Founder and Director of Deakin’s Food & Mood Centre and the International Society for Nutritional Psychiatry Research.
  • Cited in more than 100 policy documents globally, including by WHO and UNICEF, as well as influencing clinical practice guidelines in psychiatry in Australia and beyond.

Alfred Deakin Professor Michael Berk

Psychiatry and Psychology

Prof. Berk is the Director of IMPACT and leads the Mental Health Australia General Clinical Trial Network (MAGNET) funded by the Medical Research Future Fund (MRFF).

  • Known as one of the world’s leading scientific minds, according to Thompson Reuters ISI (2015-2020).
  • Ranked the top expert in the world in the field of psychiatry according to expertscape.
  • Awarded grants from the ARC, MRFF, National Health and Medical Research Council (NHMRC), Wellcome Trust, Stanley Medical Research Institute, Centre of Research Excellence, Australian Research Council, Patient-Centred Outcomes Research Institute and Congressionally Directed Medical Research Programs.
  • Published over 1400 scientific papers across his career.
  • Received Victoria’s highest scientific honour, the Victoria Prize for Science and Innovation in 2019.

Professor Alison Yung

Psychiatry and Psychology

Prof. Yung is the Leader of IMPACT’s Mental Health and Neuroscience theme, and has appeared on the Highly Cited Researchers list since 2015.

  • Developed the criteria for identifying individuals at high risk for psychosis and created a crucial instrument to assess risk, called the Comprehensive Assessment of At Risk Mental States (CAARMS).
  • Awarded the Founders’ Medal by the Society of Mental Health Research to recognise how she has transformed treatment delivery for people with early psychosis.
  • Received the Schizophrenia International Research Society’s Outstanding Translational Research Award
  • President of the IEPA Early Intervention in Mental Health.
  • Established the first clinic in the world for individuals identified as being at imminent high risk of psychotic disorder, otherwise known as ultra-high risk (UHR).


Dr Andre Caravlho

Psychiatry and Psychology

Dr Carvalho is an honorary researcher at IMPACT with expertise in evidence-based mental health, reproducibility in neuroscience, consultation-liaison psychiatry and mood and psychotic disorders.

  • Expert in evidence-based mental health, reproducibility in neuroscience, consultation-liaison psychiatry and mood and psychotic disorders.
  • Psychiatrist working as an honorary researcher at the University.
  • Ranked third in the world for his expertise in psychiatry according to expertscape.

Find out more about the Clarivate™ Highly Cited Researchers™ list here.